Evidence map›Paper›PMID 42782894›Full record

ReviewCurrent oncology (Toronto, Ont.)2026

Cell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease.

Kylie Lepic, Joseph Aziz, Gizelle Popradi, Christopher Lemieux, Jennifer White, Stephanie Maier, Mohamed Elemary, Kirk Schultz, Kristjan Paulson, Ram Vasudevan Nampoothiri and 2 more

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kylie LepicJuravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.ORCID 0000-0002-7287-0924
Joseph AzizJuravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.ORCID 0009-0009-6299-493X
Gizelle PopradiMcGill University Health Centre, Montreal, QC H4P 2P5, Canada.
Christopher LemieuxCHU de Québec, Université Laval, Québec, QC G1R 2J6, Canada.ORCID 0000-0002-0281-5866
Jennifer WhiteVancouver General Hospital, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Stephanie MaierCell Therapy Transplant Canada, Winnipeg, MB R3P 2R8, Canada.
Mohamed ElemarySaskatchewan Cancer Agency, University of Saskatchewan, Saskatchewan, SK S7N 4H4, Canada.ORCID 0000-0002-7622-4065
Kirk SchultzBritish Columbia Children's Hospital, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Kristjan PaulsonCancer Care Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Ram Vasudevan NampoothiriOttawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
David AllanOttawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.ORCID 0000-0003-3261-8289
Dennis Dong Hwan KimPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a consensus-based Canadian review with the primary purpose of expanding knowledge regarding supportive and topical therapies for chronic graft vs. host disease (cGvHD). There is often a lack of confidence in treating certain organ specific manifestations, and access to specialists with organ specific expertise varies across the country. This paper covers information gained from a literature review and Canadian transplanter expertise and will serve as a guide for hematopoietic cell transplant healthcare providers to topical cGvHD therapies accessible in Canada. We will review common symptoms and signs focused specifically on skin, mouth, eye and genital tract cGvHD and on lifestyle modifications and topical treatments as an adjunct to our recent publication on systemic treatment for cGvHD.

Indexed as

Cell- and Tissue-Based TherapyGraft vs Host DiseaseAdministration, TopicalCanadaChronic DiseaseHumansallogeneic cell transplantationchronic GvHDlifestyle modificationssupportive caretopical

Identifiers

PMID42782894
PMCPMC13605794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.